Cefpodoxime Proxetil

This page contains recent news articles, when available, and an overview of Cefpodoxime Proxetil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Learn about the World Antibiotics Market  -  Sep 24, 2008
Trials II-31SmPC For Sanofi-Aventis' Ketek® Updated II-31Lupin Receives Approval for Cefpodoxime Proxetil AntiobioticTablets in France II-31Antibiotice International Business Times,

Learn about the World Antibiotics Market  -  Sep 24, 2008
Ceftobiprole II-20 GSK Receives Approval for ALTARGO® in Europe II-20 APL Receives FDA Approval for Cefpodoxime Proxetil II-21 Cubist Receives Approval Earthtimes (press release),

Lupin`s sales to grow at 17% CAGR over next 2 yrs: Enam  -  Sep 27, 2008
...product specific strategy for the UK and France , where it currently sells one product each – lisinopril in the UK and cefpodoxime proxetil in France . Myiris.com,

Pharma pops brand-extension pill  -  Jun 27, 2008
Or, take the case of Alkem Labs rolling out extensions for its cefpodoxime proxetil brand, ‘Swich’. Even a popular drug like Voveran has seen a brand Economic Times,

Emerging Antimicrobial Resistance in Neisseria gonorrhoeae: Urgent ...  -  Apr 14, 2008
Hall C, McElroy M, Samuel M, Guerry S, Ried C, Rietmeijer C, Philip S, Katz A, Bauer H, Newman L, Bolan G. Single-dose Cefpodoxime proxetil effective Annals of Internal Medicine

LIC picks additional 2.3% stake in Orchid Chemicals  -  Mar 6, 2008
...had obtained approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for cefpodoxime proxetil tablets. TopNews,

Mission brand building  -  Jan 24, 2008
Recently, we have taken brand building initiatives for Oxipod (Cefpodoxime proxetil), MCBM 69 (A combination of Methylcobalamin, Pyridoxine and Folic acid), Express Pharma,

Orchid Chemicals receives nod for Cefpodoxime Proxetil tablets  -  Nov 16, 2007
MUMBAI: Orchid Chemicals & Pharmaceuticals Ltd has received approval from the USFDA for the Cefpodoxime Proxetil tablets, in dosage strengths of 100 mg and Economic Times,

India's Orchid Chemicals gets US FDA approval for Cefpodoxime ...  -  Nov 16, 2007
Pharmaceuticals Ltd said it received approval for from the US FDA for its abbreviated new drug application (ANDA) for Cefpodoxime Proxetil Tablets. Forbes,

Sensex remains slippery  -  Nov 16, 2007
The company has announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefpodoxime Proxetil Tablets. Sify,

Lupin: Buy  -  Oct 27, 2007
Lupin has also launched oral third-generation cephalosporin, Cefpodoxime Proxetil tabs, in France which is expected to do well. Sify,

Lupin's Q2 net up 46%  -  Oct 24, 2007
The company also launched Cefpodoxime Proxetil tabs in France. API revenues from the developing markets (including India) were 31 per cent higher at Rs NDTV.com,

FDA Safety Changes: Fluoroquinolones and Other Antimicrobial Drugs  -  Sep 26, 2007
Sulfamethoxazole/trimethoprim, cefadroxil monohydrate, nitrofurantoin monohydrate, cefpodoxime proxetil, ciprofloxacin, ofloxacin, and levofloxacin are Medscape (subscription)

Lupin to invest Rs200 crore in new plant, capacity addition  -  Aug 10, 2007
Lupin is the only company so far to get marketing approval in France for Cefpodoxime Proxetil, the generic equivalent of Sanofi Aventis's bacterial domain-B,

OFFICIAL CORRECTION Aurobindo still awaiting cefpodoxime proxetil ...  -  Jun 6, 2007
Forbes,The company said in a statement to the Bombay Stock Exchange that it 'regrets its earlier announcement of cefpodoxime proxetil approval which was displayed

Aurobindo receives USFDA Approval for Cefpodoxime proxetil Tablets  -  Jun 15, 2007
Equity Bulls,Cefpodoxime proxetil Tablets in the strengths of 100mg and 200mg has been approved. This is the 7th cephalosporin approval for the Company.

Aurobindo gets US nod for Ciprofloxin tablets  -  Jun 5, 2007
Economic Times,In a filing to the Bombay Stock Exchange, Aurobindo Pharma said, "The company regrets its earlier announcement of Cefpodoxime Proxetil approval,

Indices firm; capital goods lead  -  Jun 15, 2007
Economic Times,Aurobindo Pharma was up 0.18% at Rs 754 on US FDA approving the company’s Cefpodoxime proxetil tablets. Hindustan DorrOliver surged 5% on the company

Aurobindo Pharma gets USFDA approval for its Cefpodoxime oral ...  -  Jun 4, 2007
Equity Bulls,Cefpodoxime proxetil for oral suspension in the strengths of 50mg/5ml and 100mg/5ml has been approved. This is the 6th cephalosporin approval for the

Aurobindo Pharma gets USFDA nod for Cefpodoxime  -  Jun 4, 2007
Myiris.com,The approval was given to Cefpodoxime proxetil for oral suspension in the strengths of 50mg /5ml and 100mg / 5ml. Cefpodoxime is the generic version of

Aurobindo Pharma gets USFDA approval for Trandolapril tablets  -  Jun 15, 2007
Myiris.com,The USFDA recently approved company`s Cefpodoxime proxetil tablets in the strengths of 100mg and 200mg. Shares of the company were last trading down Rs 2.15

Aurobindo receives USFDA Approval for its Ciprofloxacin  -  Jun 5, 2007
Equity Bulls,..."Further the Company has informed that, the Company regrets its earlier announcement of cefpodoxime proxetil approval which was displayed by the FDA.

Aurobindo, Orchid get USFDA nod  -  Jun 15, 2007
Business Standard,APL has received approval for third generation Cefpodoxime proxetil tablets in the strengths of 100milligrams (mg) and 200mg.

Lupin to market Cefpodoxime Proxetil in France  -  Apr 4, 2007
Express Pharma,Lupin with its French regulatory agent Venipharm has received the marketing approval for generic Cefpodoxime Proxetil 100 mg tablets in France.

Lupin recives US FDA for formulation of Suprax  -  Apr 12, 2007
Myiris.com,Further in March 2007, it received the marketing approval for generic Cefpodoxime Proxetil 100mg tablets in France. Shares of the company were last trading

:
 
Web health.mongabay.com


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM